Agglutinin Disease, Cold
1 clinical trials · Condition
◉ Watch Agglutinin Disease, Cold
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study) (NCT03347396) | Bioverativ, a Sanofi company | 2018-03-05 |
Track Agglutinin Disease, Cold automatically
Every clearance here is in the API, with alerts when new ones post.